Net sales of the company rose by 2.63% to Rs 5,980 cr
Gross NPA at 0.91% compared to 0.95% q-o-q; NIM at 4.2%
Income from operations rises 2.26% to Rs 6,098 crore
Firm's total income up 31% to Rs 1,985 cr, Board declares third interim dividend of Rs 9 per share for FY16
Net sales for the quarter under review came in at Rs 1,557.46 crore, up 6.3%
Total income from operations declined 18.67% to Rs 605.73 crore
India's rural consumption of automobiles has been under pressure since the past year due to erratic and deficient rainfall
Biocon earned Rs 203 cr from share sale of 11% in Syngene
The total income was up by 25% at Rs 1,811 cr
Revenue for the July to September period grew by 28% to Rs 262.4 crore
The consolidated income from operations recorded a growth 35% year-on-year
Firm's topline up 18.2% to Rs 48.2 cr; Performance driven by healthy addition in RGUs, which stood at 571,834
During the period its revenue went up by 16.8% from same period last year
Revenue up by 18% in Q2
Other income declined by 7% to Rs 182 cr
The company's revenues went up 4% at Rs 1,472 cr
The company's net sales in the quarter under review rose to Rs 607.45 crore, up 13.42%
The company's net sales in the quarter under review stood at Rs 400.73 crore, up 8.9%
Net down 7.9% at Rs 1,726 crore owing to one-time client provision
The cement maker, part of Aditya Birla Group, had clocked a net of Rs 414 crore in the year-ago period